INAB In8bio, Inc.
Fundamentals / CIK 0001740279 / USDIn8bio, Inc. reported $18.70M in total assets and a net loss of $19.41M through December 31, 2025 from SEC EDGAR filings.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open INAB in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue FY 2025-- Dec 31, 2025
-
Operating Income FY 2025-$19.41M Operating profit
-
Net Income FY 2025-$19.41M GAAP bottom line
-
Diluted EPS FY 2025-$1.00 Split-adjusted
-
Free Cash Flow FY 2025-- Operating CF less CapEx
-
Cash & ST Investments Sep 30, 2026$13.97M Total debt: $2.75M
Annual revenue and net income
6 fiscal years (2020 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Research & Development | $10.21M | $16.96M | $16.83M | $14.06M | $7.35M | $5.38M |
| Total Operating Expenses | $19.86M | $30.67M | $30.34M | $28.52M | $14.65M | $8.56M |
| Operating Income | -$19.44M | -$30.44M | -$30.01M | -$28.52M | -$14.65M | -$8.56M |
| EBITDA | -$18.44M | -$29.46M | -$29.05M | -$28.37M | -$14.56M | -$8.47M |
| Interest Income | $421K | $230K | $0 | -- | -- | -- |
| Income Before Tax | -$19.44M | -$30.68M | -- | -- | -- | -- |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$19.44M | -$30.44M | -$30.01M | -$28.52M | -$14.65M | -$8.56M |
| Basic EPS | -$144.16 | -$553.57 | -$975.00 | -$1,326.00 | -$1,433.25 | -$2,944.50 |
| Diluted EPS | -$144.16 | -$553.57 | -$975.00 | -$1,326.00 | -$1,433.25 | -$2,944.50 |
| Basic Shares Outstanding | 134.7K | 55.0K | 30.6K | 21.5K | 10.2K | 3.5K |
| Diluted Shares Outstanding | 134.7K | 55.0K | 30.6K | 21.5K | 10.2K | 3.5K |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Research & Development | $2.60M | $2.49M | $2.61M | $2.65M | $2.10M | $2.49M | $2.97M | $3.59M |
| Total Operating Expenses | $4.72M | $4.93M | $5.27M | $5.03M | $3.97M | $5.20M | $5.66M | $6.22M |
| Operating Income | -$4.59M | -$4.78M | -$5.09M | -$4.94M | -$3.85M | -$5.09M | -$5.55M | -$6.16M |
| EBITDA | -$4.09M | -$4.48M | -$4.84M | -$4.70M | -$3.65M | -$4.79M | -$5.29M | -$5.91M |
| Interest Income | $129K | $154K | $176K | $91K | $113K | $107K | $110K | $64K |
| Net Income | -$4.59M | -$4.78M | -$5.09M | -$4.94M | -$3.85M | -$5.09M | -$5.55M | -$6.16M |
| Basic EPS | -$0.24 | -$0.25 | -$0.26 | -- | -$0.85 | -$1.24 | -$2.16 | -- |
| Diluted EPS | -$0.24 | -$0.25 | -$0.26 | -- | -$0.85 | -$1.24 | -$2.16 | -- |
| Basic Shares Outstanding | 19.5M | 19.5M | 19.5M | -- | 4.5M | 4.1M | 2.6M | -- |
| Diluted Shares Outstanding | 19.5M | 19.5M | 19.5M | -- | 4.5M | 4.1M | 2.6M | -- |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $27.09M | $11.12M | $21.28M | $18.18M | $37.02M | $17.99M |
| Cash & Short-Term Investments | $27.09M | $11.12M | $21.28M | $18.18M | $37.02M | $17.99M |
| Other Current Assets | $259K | $298K | $270K | $232K | $52K | $0 |
| Total Current Assets | $27.88M | $12.58M | $24.62M | $22.23M | $38.98M | $18.14M |
| Property, Plant & Equipment, Net | $1.86M | $2.86M | $3.51M | $4.40M | $97K | $186K |
| Other Non-Current Assets | $146K | $275K | $255K | $255K | $158K | $0 |
| Total Non-Current Assets | $4.40M | $8.37M | $9.08M | $10.80M | $3.24M | $2.77M |
| Total Assets | $32.28M | $20.94M | $33.71M | $33.04M | $42.22M | $20.91M |
| Accounts Payable | $309K | $389K | $924K | $2.09M | $395K | $620K |
| Total Current Liabilities | $3.16M | $3.08M | $5.39M | $5.82M | $2.26M | $2.57M |
| Total Non-Current Liabilities | $1.56M | $3.38M | $3.38M | $4.49M | $1.78M | $17K |
| Total Liabilities | $4.72M | $6.47M | $8.77M | $10.31M | $4.04M | $2.59M |
| Total Debt (incl. Leases) | $2.78M | $5.03M | $4.89M | $5.87M | $2.41M | -- |
| Common Stock | $10K | $7.0K | $4.0K | $3.0K | $2.0K | $1.0K |
| Retained Earnings | -$141.1M | -$121.7M | -$91.22M | -$61.21M | -$32.69M | -$18.04M |
| Total Stockholders' Equity | $27.56M | $14.48M | $24.94M | $22.73M | -$38.18M | -$16.58M |
| Total Equity | $27.56M | $14.48M | $24.94M | $22.73M | -$38.18M | -$16.58M |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $13.97M | $17.96M | $21.94M | $27.09M | $10.69M | $13.23M | $11.89M | $11.12M |
| Cash & Short-Term Investments | $13.97M | $17.96M | $21.94M | $27.09M | $10.69M | $13.23M | $11.89M | $11.12M |
| Other Current Assets | $495K | $364K | $395K | $259K | $346K | $367K | $427K | $298K |
| Total Current Assets | $15.19M | $18.50M | $22.66M | $27.88M | $11.77M | $13.74M | $12.72M | $12.58M |
| Property, Plant & Equipment, Net | $1.34M | $1.60M | $1.62M | $1.86M | $2.10M | $2.35M | $2.60M | $2.86M |
| Other Non-Current Assets | $102K | $102K | $129K | $146K | $169K | $275K | $275K | $275K |
| Total Non-Current Assets | $3.50M | $3.25M | $3.60M | $4.40M | $5.00M | $5.63M | $7.14M | $8.37M |
| Total Assets | $18.70M | $21.75M | $26.27M | $32.28M | $16.77M | $19.37M | $19.87M | $20.94M |
| Accounts Payable | $493K | $444K | $449K | $309K | $204K | $379K | $575K | $389K |
| Total Current Liabilities | $2.63M | $2.25M | $2.16M | $3.16M | $1.70M | $1.95M | $2.96M | $3.08M |
| Total Non-Current Liabilities | $1.89M | $1.13M | $1.33M | $1.56M | $1.88M | $2.18M | $3.04M | $3.38M |
| Total Liabilities | $4.52M | $3.38M | $3.48M | $4.72M | $3.58M | $4.13M | $5.99M | $6.47M |
| Total Debt (incl. Leases) | $2.75M | $2.18M | $2.35M | $2.78M | $2.96M | $3.12M | $4.27M | $5.03M |
| Common Stock | $10K | $10K | $10K | $10K | $10K | $10K | $8.0K | $7.0K |
| Retained Earnings | -$155.6M | -$151.0M | -$146.2M | -$141.1M | -$136.2M | -$132.3M | -$127.2M | -$121.7M |
| Total Stockholders' Equity | $14.17M | $18.36M | $22.78M | $27.56M | $13.19M | $15.24M | $13.88M | $14.48M |
| Total Equity | $14.17M | $18.36M | $22.78M | $27.56M | $13.19M | $15.24M | $13.88M | $14.48M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Net Income | -$19.44M | -$30.44M | -$30.01M | -$28.52M | -$14.65M | -$8.56M |
| Depreciation & Amortization | $1.00M | $976K | $962K | $147K | $89K | $88K |
| Stock-Based Compensation | $3.19M | $5.00M | $4.37M | $3.47M | $2.19M | $357K |
| Change in Payables | -$80K | -$535K | -$981K | $1.51M | -$319K | -$160K |
| Operating Cash Flow | -$12.71M | -$24.15M | -$23.34M | -$24.12M | -$13.51M | -$7.13M |
| Investing Cash Flow | $0 | -$187K | -$600K | -$3.71M | -$309K | $0 |
| Common Stock Issued | $8.57M | $3.82M | $14.38M | $9.54M | $36.33M | $499K |
| Financing Cash Flow | $28.64M | $14.18M | $27.04M | $8.99M | $32.95M | $24.52M |
| Net Change in Cash | $15.93M | -$10.15M | $3.10M | -$18.84M | $19.14M | $17.38M |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$4.59M | -$4.78M | -$5.09M | -$4.94M | -$3.85M | -$5.09M | -$5.55M | -$6.16M |
| Depreciation & Amortization | $500K | $300K | $245K | $245K | $200K | $300K | $256K | $251K |
| Stock-Based Compensation | $397K | $352K | $401K | $711K | $692K | $955K | $831K | $825K |
| Change in Payables | $49K | -$5.0K | $140K | $105K | -$175K | -$196K | $186K | -$746K |
| Operating Cash Flow | -$3.93M | -$3.75M | -$4.95M | -$2.14M | -$3.52M | -$3.93M | -$3.12M | -$4.03M |
| Capital Expenditure | -- | -- | -- | -- | $0 | $0 | $0 | -- |
| Free Cash Flow | -- | -- | -- | -- | -$3.52M | -$3.93M | -$3.12M | -- |
| Investing Cash Flow | $1.0K | -$233K | -$9.0K | $0 | $0 | $0 | $0 | -$33K |
| Common Stock Issued | $0 | $0 | $0 | $102K | $1.11M | $3.62M | $3.73M | $3.90M |
| Financing Cash Flow | -$56K | -$51K | -$195K | $18.49M | $989K | $5.27M | $3.89M | $11.19M |
| Net Change in Cash | -$3.98M | -$4.03M | -$5.15M | $16.35M | -$2.54M | $1.34M | $771K | $7.13M |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -70.5% | -210.2% | -120.3% | -125.5% | -- | -- |
| Return on Assets (ROA) | -60.2% | -145.3% | -89.0% | -86.3% | -34.7% | -40.9% |
| Current Ratio | 8.82x | 4.08x | 4.57x | 3.82x | 17.28x | 7.05x |
| Quick Ratio | 8.57x | 3.61x | 3.95x | 3.12x | 16.41x | 7.00x |
| Debt to Equity | 0.10x | 0.35x | 0.20x | 0.26x | -- | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -136.9% | -101.7% | -83.3% | -70.5% | -156.6% | -156.8% | -197.6% | -210.2% |
| Return on Assets (ROA) | -103.8% | -85.8% | -72.3% | -60.2% | -123.2% | -123.3% | -138.0% | -145.3% |
| Current Ratio | 5.78x | 8.21x | 10.50x | 8.82x | 6.91x | 7.03x | 4.30x | 4.08x |
| Quick Ratio | 5.32x | 7.97x | 10.17x | 8.57x | 6.28x | 6.77x | 4.02x | 3.61x |
| Debt to Equity | 0.19x | 0.12x | 0.10x | 0.10x | 0.22x | 0.20x | 0.31x | 0.35x |